Benefits and risks of bisphosphonate therapy for osteoporosis / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 953-955, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-430354
ABSTRACT
Bisphosphonates have been efficacious in preventing bone loss and reducing fractures in men and postmenopausal women with osteoporosis.Possible risks of osteonecrosis of the jaw and atypical femur fractures have been reported with bisphosphonates treatment,despite these incidences are very low.Oral bisphosphonates are associated with upper gastrointestinal side effects and iv bisphosphonates with acute phase reactions,the association of bisphosphonate use with esophageal cancer and atrial fibrillation is not well supported by current data.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de etiología
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS